Decheng Capital Management III »

Seagen shares owned by Decheng Capital Management III

Quarter-by-quarter ownership of Seagen shares owned by Decheng Capital Management III from 13F filings

Historical chart of Decheng Capital Management III investment in Seagen

Tip: Access up to 7 years of quarterly data

All positions including Seagen held by Decheng Capital Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seagen by Decheng Capital Management III

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.9M 23k 212.15

More positions owned by Decheng Capital Management III

Alpine Immune Sciences (ALPN)
Zentalis Pharmaceuticals (ZNTL)
Aura Biosciences (AURA)
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Acelyrin (SLRN)
Arcus Biosciences Incorporated (RCUS)
10x Genomics Cl A Com (TXG)
Argenx SE SHS (ARGX)
Pacific Biosciences of California (PACB)
Illumina (ILMN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Horizon Therapeutics
Phathom Pharmaceuticals (PHAT)
ImmunoGen
Seagen

View all positions for Decheng Capital Management III

Top funds holding Seagen

First City Capital Management
IFP Advisors
Spotlight Asset Group

View all funds holding Seagen